149 related articles for article (PubMed ID: 16905646)
1. Peripheral insensate neuropathy--a tall problem for US adults?
Cheng YJ; Gregg EW; Kahn HS; Williams DE; De Rekeneire N; Narayan KM
Am J Epidemiol; 2006 Nov; 164(9):873-80. PubMed ID: 16905646
[TBL] [Abstract][Full Text] [Related]
2. Peripheral insensate neuropathy-is height a risk factor?
Kote GS; Bhat AN; K T; Ismail MH; Gupta A
J Clin Diagn Res; 2013 Feb; 7(2):296-301. PubMed ID: 23542767
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey.
Gregg EW; Sorlie P; Paulose-Ram R; Gu Q; Eberhardt MS; Wolz M; Burt V; Curtin L; Engelgau M; Geiss L;
Diabetes Care; 2004 Jul; 27(7):1591-7. PubMed ID: 15220233
[TBL] [Abstract][Full Text] [Related]
4. Evidence of nephropathy and peripheral neuropathy in US adults with undiagnosed diabetes.
Koopman RJ; Mainous AG; Liszka HA; Colwell JA; Slate EH; Carnemolla MA; Everett CJ
Ann Fam Med; 2006; 4(5):427-32. PubMed ID: 17003143
[TBL] [Abstract][Full Text] [Related]
5. Peripheral neuropathy defined by monofilament insensitivity and diabetes status: NHANES 1999-2004.
Katon JG; Reiber GE; Nelson KM
Diabetes Care; 2013 Jun; 36(6):1604-6. PubMed ID: 23275365
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of peripheral neuropathy severe enough to cause a loss of protective sensation in a population-based sample of people with known and newly detected diabetes in Barbados: a cross-sectional study.
Adams OP; Herbert JR; Howitt C; Unwin N
Diabet Med; 2019 Dec; 36(12):1629-1636. PubMed ID: 31094005
[TBL] [Abstract][Full Text] [Related]
7. Association of statin use with peripheral neuropathy in the U.S. population 40 years of age or older.
Tierney EF; Thurman DJ; Beckles GL; Cadwell BL
J Diabetes; 2013 Jun; 5(2):207-15. PubMed ID: 23121724
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for diabetic peripheral sensory neuropathy. Results of the Seattle Prospective Diabetic Foot Study.
Adler AI; Boyko EJ; Ahroni JH; Stensel V; Forsberg RC; Smith DG
Diabetes Care; 1997 Jul; 20(7):1162-7. PubMed ID: 9203456
[TBL] [Abstract][Full Text] [Related]
9. Relationship between peripheral neuropathy and cognitive performance in the elderly population.
Lin YJ; Kao TW; Chen WL
Medicine (Baltimore); 2021 May; 100(20):e26071. PubMed ID: 34011128
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of neuropathy in type 2 diabetic patients and its association with other diabetes complications: The Verona Diabetic Foot Screening Program.
Salvotelli L; Stoico V; Perrone F; Cacciatori V; Negri C; Brangani C; Pichiri I; Targher G; Bonora E; Zoppini G
J Diabetes Complications; 2015; 29(8):1066-70. PubMed ID: 26227575
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of peripheral neuropathy defined by monofilament insensitivity in middle-aged and older adults in two US cohorts.
Hicks CW; Wang D; Windham BG; Matsushita K; Selvin E
Sci Rep; 2021 Sep; 11(1):19159. PubMed ID: 34580377
[TBL] [Abstract][Full Text] [Related]
12. Physical activity, glycemic control, and diabetic peripheral neuropathy: a national sample.
Loprinzi PD; Hager KK; Ramulu PY
J Diabetes Complications; 2014; 28(1):17-21. PubMed ID: 24090951
[TBL] [Abstract][Full Text] [Related]
13. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity and glycaemic control.
Sorensen L; Molyneaux L; Yue DK
Diabetes Res Clin Pract; 2002 Jul; 57(1):45-51. PubMed ID: 12007729
[TBL] [Abstract][Full Text] [Related]
14. Association between vitamin D and diabetic neuropathy in a nationally representative sample: results from 2001-2004 NHANES.
Soderstrom LH; Johnson SP; Diaz VA; Mainous AG
Diabet Med; 2012 Jan; 29(1):50-5. PubMed ID: 21726279
[TBL] [Abstract][Full Text] [Related]
15. Relationship of polyunsaturated fatty acid intake to peripheral neuropathy among adults with diabetes in the National Health and Nutrition Examination Survey (NHANES) 1999 2004.
Tao M; McDowell MA; Saydah SH; Eberhardt MS
Diabetes Care; 2008 Jan; 31(1):93-5. PubMed ID: 17914029
[TBL] [Abstract][Full Text] [Related]
16. Lower extremity disease among persons aged > or =40 years with and without diabetes--United States, 1999-2002.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2005 Nov; 54(45):1158-60. PubMed ID: 16292250
[TBL] [Abstract][Full Text] [Related]
17. Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001-2004.
Ylitalo KR; Sowers M; Heeringa S
Diabetes Care; 2011 Jul; 34(7):1642-7. PubMed ID: 21593304
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical characteristics of diabetic peripheral neuropathy in hospital patients with Type 2 diabetes in Korea.
Won JC; Kwon HS; Kim CH; Lee JH; Park TS; Ko KS; Cha BY
Diabet Med; 2012 Sep; 29(9):e290-6. PubMed ID: 22519862
[TBL] [Abstract][Full Text] [Related]
19. Monofilament insensitivity and small and large nerve fiber symptoms in impaired fasting glucose.
Ylitalo KR; Herman WH; Harlow SD
Prim Care Diabetes; 2013 Dec; 7(4):309-13. PubMed ID: 23896181
[TBL] [Abstract][Full Text] [Related]
20. Control of risk factors among people with diagnosed diabetes, by lower extremity disease status.
Dorsey RR; Eberhardt MS; Gregg EW; Geiss LS
Prev Chronic Dis; 2009 Oct; 6(4):A114. PubMed ID: 19754990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
